299 related articles for article (PubMed ID: 9741641)
1. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.
Gale MJ; Korth MJ; Katze MG
Clin Diagn Virol; 1998 Jul; 10(2-3):157-62. PubMed ID: 9741641
[TBL] [Abstract][Full Text] [Related]
2. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.
Gale MJ; Korth MJ; Tang NM; Tan SL; Hopkins DA; Dever TE; Polyak SJ; Gretch DR; Katze MG
Virology; 1997 Apr; 230(2):217-27. PubMed ID: 9143277
[TBL] [Abstract][Full Text] [Related]
3. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
[TBL] [Abstract][Full Text] [Related]
4. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells.
Noguchi T; Satoh S; Noshi T; Hatada E; Fukuda R; Kawai A; Ikeda S; Hijikata M; Shimotohno K
Microbiol Immunol; 2001; 45(12):829-40. PubMed ID: 11838900
[TBL] [Abstract][Full Text] [Related]
5. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.
Gale M; Blakely CM; Kwieciszewski B; Tan SL; Dossett M; Tang NM; Korth MJ; Polyak SJ; Gretch DR; Katze MG
Mol Cell Biol; 1998 Sep; 18(9):5208-18. PubMed ID: 9710605
[TBL] [Abstract][Full Text] [Related]
6. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.
Nousbaum J; Polyak SJ; Ray SC; Sullivan DG; Larson AM; Carithers RL; Gretch DR
J Virol; 2000 Oct; 74(19):9028-38. PubMed ID: 10982347
[TBL] [Abstract][Full Text] [Related]
7. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.
Pawlotsky JM; Germanidis G; Neumann AU; Pellerin M; Frainais PO; Dhumeaux D
J Virol; 1998 Apr; 72(4):2795-805. PubMed ID: 9525599
[TBL] [Abstract][Full Text] [Related]
8. NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/ribavirin therapy.
Bouzgarrou N; Hassen E; Mahfoudh W; Gabbouj S; Schvoerer E; Ben Yahia A; Ben Mami N; Triki H; Chouchane L
J Med Virol; 2009 Dec; 81(12):2021-8. PubMed ID: 19856481
[TBL] [Abstract][Full Text] [Related]
9. Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection.
Murphy MD; Rosen HR; Marousek GI; Chou S
Dig Dis Sci; 2002 Jun; 47(6):1195-205. PubMed ID: 12064791
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin.
Hung CH; Lee CM; Lu SN; Lee JF; Wang JH; Tung HD; Chen TM; Hu TH; Chen WJ; Changchien CS
J Viral Hepat; 2003 Mar; 10(2):87-94. PubMed ID: 12614464
[TBL] [Abstract][Full Text] [Related]
11. Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-alpha.
Gerotto M; Dal Pero F; Sullivan DG; Chemello L; Cavalletto L; Polyak SJ; Pontisso P; Gretch DR; Alberti A
J Viral Hepat; 1999 Sep; 6(5):367-72. PubMed ID: 10607252
[TBL] [Abstract][Full Text] [Related]
12. Variability of the nonstructural 5A protein of hepatitis C virus type 3a isolates and relation to interferon sensitivity.
Castelain S; Khorsi H; Roussel J; François C; Jaillon O; Capron D; Penin F; Wychowski C; Meurs E; Duverlie G;
J Infect Dis; 2002 Mar; 185(5):573-83. PubMed ID: 11865413
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis.
François C; Duverlie G; Rebouillat D; Khorsi H; Castelain S; Blum HE; Gatignol A; Wychowski C; Moradpour D; Meurs EF
J Virol; 2000 Jun; 74(12):5587-96. PubMed ID: 10823866
[TBL] [Abstract][Full Text] [Related]
14. The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.
Tsai YH; Kuang WF; Lu TY; Kao JH; Lai MY; Liu CJ; Chen PJ; Hwang LH
J Hepatol; 2008 Dec; 49(6):899-907. PubMed ID: 18842320
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment.
Berg T; Mas Marques A; Höhne M; Wiedenmann B; Hopf U; Schreier E
Hepatology; 2000 Dec; 32(6):1386-95. PubMed ID: 11093746
[TBL] [Abstract][Full Text] [Related]
16. Mutations in two PKR-binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness.
Yokozaki S; Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
J Med Virol; 2011 Oct; 83(10):1727-32. PubMed ID: 21837788
[TBL] [Abstract][Full Text] [Related]
17. GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.
Xiang J; Martinez-Smith C; Gale M; Chang Q; Labrecque DR; Schmidt WN; Stapleton JT
J Interferon Cytokine Res; 2005 May; 25(5):261-70. PubMed ID: 15871663
[TBL] [Abstract][Full Text] [Related]
18. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.
He Y; Tan SL; Tareen SU; Vijaysri S; Langland JO; Jacobs BL; Katze MG
J Virol; 2001 Jun; 75(11):5090-8. PubMed ID: 11333890
[TBL] [Abstract][Full Text] [Related]
19. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.
Giménez-Barcons M; Franco S; Suárez Y; Forns X; Ampurdanès S; Puig-Basagoiti F; Sánchez-Fueyo A; Barrera JM; Llovet JM; Bruix J; Sánchez-Tapias JM; Rodés J; Saiz JC
Hepatology; 2001 Jul; 34(1):158-67. PubMed ID: 11431747
[TBL] [Abstract][Full Text] [Related]
20. Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin.
Sede M; Laufer N; Ojeda D; Gun A; Cahn P; Quarleri J
Arch Virol; 2013 Sep; 158(9):1907-15. PubMed ID: 23553458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
